Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa

Marion Vermeulen, Ronel Swanevelder, Dhuly Chowdhury, Charlotte Ingram, Ravi Reddy, Evan M Bloch, Brian S Custer, Edward L Murphy, NHLBI Recipient Epidemiology and Donor evaluation Study-III (REDS-III) International Component, Marion Vermeulen, Ronel Swanevelder, Dhuly Chowdhury, Charlotte Ingram, Ravi Reddy, Evan M Bloch, Brian S Custer, Edward L Murphy, NHLBI Recipient Epidemiology and Donor evaluation Study-III (REDS-III) International Component

Abstract

Among 397,640 first-time blood donors screened in South Africa during 2012-2015, HIV prevalence was 1.13%, hepatitis B virus prevalence 0.66%, and hepatitis C virus prevalence 0.03%. Findings of note were a high HIV prevalence in Mpumalanga Province and the near absence of hepatitis C virus nationwide.

Keywords: HIV; South Africa; blood donors; hepatitis; hepatitis B virus; hepatitis C virus; prevalence; viruses.

Figures

Figure
Figure
Overall prevalence of HIV (A) and hepatitis B virus (B) in South Africa, by province, among persons making blood donations through the South African National Blood Service, January 2012–September 2015. Pink indicates a significantly higher odds ratio and green indicates a lower odds ratio compared with Gauteng Province (Johannesburg region) and adjusting for other factors. Unadjusted prevalences are shown in parentheses. NA, not applicable.

References

    1. Zuma K, Shisana O, Rehle TM, Simbayi LC, Jooste S, Zungu N, et al. New insights into HIV epidemic in South Africa: key findings from the National HIV Prevalence, Incidence and Behaviour Survey, 2012. Afr J AIDS Res. 2016;15:67–75. 10.2989/16085906.2016.1153491
    1. Eaton JW, Bacaër N, Bershteyn A, Cambiano V, Cori A, Dorrington RE, et al. Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral therapy era. Lancet Glob Health. 2015;3:e598–608. 10.1016/S2214-109X(15)00080-7
    1. Amponsah-Dacosta E, Lebelo RL, Rakgole JN, Burnett RJ, Selabe SG, Mphahlele MJ. Evidence for a change in the epidemiology of hepatitis B virus infection after nearly two decades of universal hepatitis B vaccination in South Africa. J Med Virol. 2014;86:918–24. 10.1002/jmv.23910
    1. Tucker TJ, Voigt M, Bird A, Robson S, Gibbs B, Kannemeyer J, et al. Hepatitis C virus infection rate in volunteer blood donors from the Western Cape—comparison of screening tests and PCR. S Afr Med J. 1997;87:603–5.
    1. Rao VB, Johari N, du Cros P, Messina J, Ford N, Cooke GS. Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15:819–24. 10.1016/S1473-3099(15)00006-7
    1. Bruhn R, Lelie N, Custer B, Busch M, Kleinman S; International NAT Study Group. Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios. Transfusion. 2013;53:2399–412. 10.1111/trf.12299
    1. Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, et al. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion. 2009;49:1115–25. 10.1111/j.1537-2995.2009.02110.x
    1. Bloch EM, Vermeulen M, Murphy E. Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges. Transfus Med Rev. 2012;26:164–80. 10.1016/j.tmrv.2011.07.006
    1. Rehle T, Johnson L, Hallett T, Mahy M, Kim A, Odido H, et al. A comparison of South African national HIV incidence estimates: a critical appraisal of different methods. PLoS One. 2015;10:e0133255. 10.1371/journal.pone.0133255
    1. Johnson LF, Rehle TM, Jooste S, Bekker LG. Rates of HIV testing and diagnosis in South Africa: successes and challenges. AIDS. 2015;29:1401–9. 10.1097/QAD.0000000000000721
    1. Apata IW, Averhoff F, Pitman J, Bjork A, Yu J, Amin NA, et al.; Centers for Disease Control and Prevention (CDC). Progress toward prevention of transfusion-transmitted hepatitis B and hepatitis C infection—sub-Saharan Africa, 2000-2011. MMWR Morb Mortal Wkly Rep. 2014;63:613–9.
    1. Custer B, Kessler D, Vahidnia F, Leparc G, Krysztof DE, Shaz B, et al.; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II). Risk factors for retrovirus and hepatitis virus infections in accepted blood donors. Transfusion. 2015;55:1098–107. 10.1111/trf.12951
    1. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(Suppl):S45–57. 10.1016/j.jhep.2014.07.027
    1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57:1333–42. 10.1002/hep.26141

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit